Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization.
Two-thirds of patients affected by Duchenne or Becker muscular dystrophy (DMD/BMD) carry large intra-genic deletions in the dystrophin gene. In males, the deletions can be efficiently detected using multiplex polymerase chain reaction (PCR) and Southern blotting. In contrast, deletion detection in carrier females is complicated by the presence of a normal gene copy on the second X-chromosome. We have analyzed the boundaries of 570 deletions and 34 duplications in the dystrophin gene identified in the São Paulo and Leiden diagnostic laboratories. The data were used to select an optimal set of cosmid probes for the detection of the most frequently deleted areas of the dystrophin gene. Six cosmids were evaluated in fluorescence in situ hybridization (FISH) experiments to assess deletions in 21 heterozygous deletion-carriers and nine controls. No discrepancy was found between the FISH analysis and the molecular data, demonstrating the accuracy of the technique for carrier detection in Duchenne and Becker muscular dystrophy.
Rosenberg
C
C
Department of Biology, Bioscience Institute, University of São Paulo, Brazil.
Navajas
L
L
Vagenas
D F
DF
Bakker
E
E
Vainzof
M
M
Passos-Bueno
M R
MR
Takata
R I
RI
Van Ommen
G J
GJ
Zatz
M
M
Den Dunnen
J T
JT
D015342:DNA Probes; D016189:Dystrophin / Q000235:genetics*; D005091:Exons / Q000235:genetics; D017353:Gene Deletion; D005796:Genes / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000235:genetics*
D015342:DNA Probes; D016189:Dystrophin